×
S&P 500   4,158.24 (+2.47%)
DOW   33,212.96 (+1.76%)
QQQ   309.10 (+3.26%)
AAPL   149.64 (+4.08%)
MSFT   273.24 (+2.76%)
FB   195.13 (+1.83%)
GOOGL   2,246.33 (+4.20%)
AMZN   2,302.93 (+3.66%)
TSLA   759.63 (+7.33%)
NVDA   188.11 (+5.38%)
BABA   93.41 (-1.13%)
NIO   16.57 (+3.37%)
AMD   102.26 (+3.55%)
CGC   4.88 (-12.07%)
MU   73.32 (+3.85%)
T   21.29 (-0.14%)
GE   78.76 (+2.27%)
F   13.63 (+3.89%)
DIS   109.32 (+3.51%)
AMC   14.43 (+17.99%)
PFE   53.91 (-0.15%)
PYPL   85.21 (+5.96%)
NFLX   195.19 (+1.98%)
S&P 500   4,158.24 (+2.47%)
DOW   33,212.96 (+1.76%)
QQQ   309.10 (+3.26%)
AAPL   149.64 (+4.08%)
MSFT   273.24 (+2.76%)
FB   195.13 (+1.83%)
GOOGL   2,246.33 (+4.20%)
AMZN   2,302.93 (+3.66%)
TSLA   759.63 (+7.33%)
NVDA   188.11 (+5.38%)
BABA   93.41 (-1.13%)
NIO   16.57 (+3.37%)
AMD   102.26 (+3.55%)
CGC   4.88 (-12.07%)
MU   73.32 (+3.85%)
T   21.29 (-0.14%)
GE   78.76 (+2.27%)
F   13.63 (+3.89%)
DIS   109.32 (+3.51%)
AMC   14.43 (+17.99%)
PFE   53.91 (-0.15%)
PYPL   85.21 (+5.96%)
NFLX   195.19 (+1.98%)
S&P 500   4,158.24 (+2.47%)
DOW   33,212.96 (+1.76%)
QQQ   309.10 (+3.26%)
AAPL   149.64 (+4.08%)
MSFT   273.24 (+2.76%)
FB   195.13 (+1.83%)
GOOGL   2,246.33 (+4.20%)
AMZN   2,302.93 (+3.66%)
TSLA   759.63 (+7.33%)
NVDA   188.11 (+5.38%)
BABA   93.41 (-1.13%)
NIO   16.57 (+3.37%)
AMD   102.26 (+3.55%)
CGC   4.88 (-12.07%)
MU   73.32 (+3.85%)
T   21.29 (-0.14%)
GE   78.76 (+2.27%)
F   13.63 (+3.89%)
DIS   109.32 (+3.51%)
AMC   14.43 (+17.99%)
PFE   53.91 (-0.15%)
PYPL   85.21 (+5.96%)
NFLX   195.19 (+1.98%)
S&P 500   4,158.24 (+2.47%)
DOW   33,212.96 (+1.76%)
QQQ   309.10 (+3.26%)
AAPL   149.64 (+4.08%)
MSFT   273.24 (+2.76%)
FB   195.13 (+1.83%)
GOOGL   2,246.33 (+4.20%)
AMZN   2,302.93 (+3.66%)
TSLA   759.63 (+7.33%)
NVDA   188.11 (+5.38%)
BABA   93.41 (-1.13%)
NIO   16.57 (+3.37%)
AMD   102.26 (+3.55%)
CGC   4.88 (-12.07%)
MU   73.32 (+3.85%)
T   21.29 (-0.14%)
GE   78.76 (+2.27%)
F   13.63 (+3.89%)
DIS   109.32 (+3.51%)
AMC   14.43 (+17.99%)
PFE   53.91 (-0.15%)
PYPL   85.21 (+5.96%)
NFLX   195.19 (+1.98%)
NASDAQ:ICUI

ICU Medical (ICUI) Stock Forecast, Price & News

$182.59
+3.12 (+1.74%)
(As of 05/27/2022 04:00 PM ET)
Add
Compare
Today's Range
$180.84
$184.82
50-Day Range
$173.49
$247.46
52-Week Range
$167.47
$282.00
Volume
130,198 shs
Average Volume
210,133 shs
Market Capitalization
$4.36 billion
P/E Ratio
89.51
Dividend Yield
N/A
Beta
0.48
30 days | 90 days | 365 days | Advanced Chart
Receive ICUI News and Ratings via Email

Sign-up to receive the latest news and ratings for ICU Medical and its competitors with MarketBeat's FREE daily newsletter.

ICU Medical logo

About ICU Medical

ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy and critical care applications worldwide. The company's infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; SwabCap and SwabTip disinfecting caps; Tego hemodialysis connectors; ClearGuard HD, an antimicrobial barrier cap for hemodialysis catheters; and ChemoClave and ChemoLock closed system transfer devices, as well as Diana hazardous drug compounding system for the preparation of hazardous drugs. It also provides IV therapy and diluents, such as sodium chloride, dextrose, balanced electrolyte solutions, lactated ringer's, ringer's, mannitol, sodium chloride/dextrose, and sterile water; and irrigation comprising sodium chloride and sterile water irrigation, physiologic solutions, ringer's irrigation, acetic acid irrigation, glycine irrigation, sorbitol-mannitol irrigation, flexible containers, and pour bottle options. The company offers infusion pumps under the Plum 360 and LifeCare PCA brands; IV mediation safety software, including ICU Medical MedNet, an enterprise-class medication management platform that connects smart pumps to hospital's electronic health records, asset tracking systems, and alarm notification platforms; and related professional services. It also provides critical care products, such as Cogent 2-in-1 and CardioFlo hemodynamic monitoring systems; TDQ and OptiQ cardiac output monitoring catheters; TriOx venous oximetry catheters; Transpac blood pressure transducers; and SafeSet closed blood sampling and conservation systems. The company sells its products to acute care hospitals, wholesalers, ambulatory clinics, and alternate site facilities, including outpatient clinics, home health care providers, and long-term care facilities. ICU Medical, Inc. was founded in 1984 and is headquartered in San Clemente, California.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
Health Care Supplies
Sector
Medical
Current Symbol
NASDAQ:ICUI
CUSIP
44930G10
Employees
8,500
Year Founded
1984

Sales & Book Value

Annual Sales
$1.32 billion
Cash Flow
$10.63 per share
Book Value
$91.18 per share

Profitability

Net Income
$103.14 million
Pretax Margin
2.68%

Debt

Price-To-Earnings

Miscellaneous

Free Float
22,152,000
Market Cap
$4.36 billion
Optionable
Optionable

Company Calendar

Last Earnings
5/09/2022
Today
5/27/2022
Next Earnings (Estimated)
8/03/2022
Fiscal Year End
12/31/2022

Social Links


MarketRank

Overall MarketRank

2.45 out of 5 stars

Medical Sector

170th out of 1,424 stocks

Surgical & Medical Instruments Industry

19th out of 137 stocks

Analyst Opinion: 3.5Community Rank: 4.4Dividend Strength: 0.0Insider Behavior: 2.5Valuation: 1.9 5 -4 -3 -2 -1 -













ICU Medical (NASDAQ:ICUI) Frequently Asked Questions

Is ICU Medical a buy right now?

2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for ICU Medical in the last twelve months. There are currently 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" ICU Medical stock.
View analyst ratings for ICU Medical
or view top-rated stocks.

When is ICU Medical's next earnings date?

ICU Medical is scheduled to release its next quarterly earnings announcement on Wednesday, August 3rd 2022.
View our earnings forecast for ICU Medical
.

How were ICU Medical's earnings last quarter?

ICU Medical, Inc. (NASDAQ:ICUI) issued its quarterly earnings results on Monday, May, 9th. The medical instruments supplier reported $1.32 EPS for the quarter, missing analysts' consensus estimates of $1.53 by $0.21. The medical instruments supplier had revenue of $543.10 million for the quarter, compared to analyst estimates of $557.33 million. ICU Medical had a net margin of 2.68% and a trailing twelve-month return on equity of 7.89%. ICU Medical's revenue for the quarter was up 70.8% on a year-over-year basis. During the same quarter in the prior year, the firm earned $1.34 EPS.
View ICU Medical's earnings history
.

What guidance has ICU Medical issued on next quarter's earnings?

ICU Medical issued an update on its FY 2022 earnings guidance on Thursday, March, 24th. The company provided earnings per share (EPS) guidance of $9.000-$10.500 for the period, compared to the consensus earnings per share estimate of $7.760. The company issued revenue guidance of -.

What price target have analysts set for ICUI?

2 brokerages have issued 12 month target prices for ICU Medical's shares. Their forecasts range from $265.00 to $280.00. On average, they anticipate ICU Medical's stock price to reach $272.50 in the next twelve months. This suggests a possible upside of 49.2% from the stock's current price.
View analysts' price targets for ICU Medical
or view top-rated stocks among Wall Street analysts.

Who are ICU Medical's key executives?
ICU Medical's management team includes the following people:
  • Mr. Vivek Jain, CEO & Chairman (Age 50, Pay $1.31M)
  • Mr. Brian Michael Bonnell, CFO & Treasurer (Age 48, Pay $645.5k)
  • Mr. Christian B. Voigtlander, Chief Operating Officer (Age 53, Pay $685.5k)
  • Ms. Virginia Ruth Sanzone, Corp. VP, Gen. Counsel, Sec. & Compliance Officer (Age 47, Pay $523.5k) (LinkedIn Profile)
What is Vivek Jain's approval rating as ICU Medical's CEO?

81 employees have rated ICU Medical CEO Vivek Jain on Glassdoor.com. Vivek Jain has an approval rating of 73% among ICU Medical's employees.

What other stocks do shareholders of ICU Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other ICU Medical investors own include Becton, Dickinson and (BDX), BlackRock (BLK), NVIDIA (NVDA), Alibaba Group (BABA), CA (CA), UnitedHealth Group (UNH), Boeing (BA), Micron Technology (MU), Lockheed Martin (LMT) and ServiceNow (NOW).

What is ICU Medical's stock symbol?

ICU Medical trades on the NASDAQ under the ticker symbol "ICUI."

Who are ICU Medical's major shareholders?

ICU Medical's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Vanguard Group Inc. (8.88%), BlackRock Inc. (7.01%), Wellington Management Group LLP (6.34%), JPMorgan Chase & Co. (3.36%), State Street Corp (2.34%) and Nuance Investments LLC (2.19%). Company insiders that own ICU Medical stock include Elisha W Finney, George A Lopez, Robert S Swinney, Virginia Ruth Sanzone and Vivek Jain.
View institutional ownership trends for ICU Medical
.

Which major investors are selling ICU Medical stock?

ICUI stock was sold by a variety of institutional investors in the last quarter, including Neuberger Berman Group LLC, JPMorgan Chase & Co., Woodline Partners LP, Eagle Asset Management Inc., Federated Hermes Inc., Bank of Montreal Can, TD Asset Management Inc., and BlackRock Inc.. Company insiders that have sold ICU Medical company stock in the last year include Elisha W Finney, Virginia Ruth Sanzone, and Vivek Jain.
View insider buying and selling activity for ICU Medical
or view top insider-selling stocks.

Which major investors are buying ICU Medical stock?

ICUI stock was purchased by a variety of institutional investors in the last quarter, including Wellington Management Group LLP, Vanguard Group Inc., Eaton Vance Management, GW&K Investment Management LLC, Westwood Holdings Group Inc., Arrowstreet Capital Limited Partnership, Martingale Asset Management L P, and First Trust Advisors LP.
View insider buying and selling activity for ICU Medical
or or view top insider-buying stocks.

How do I buy shares of ICU Medical?

Shares of ICUI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is ICU Medical's stock price today?

One share of ICUI stock can currently be purchased for approximately $182.59.

How much money does ICU Medical make?

ICU Medical has a market capitalization of $4.36 billion and generates $1.32 billion in revenue each year. The medical instruments supplier earns $103.14 million in net income (profit) each year or $2.039990 on an earnings per share basis.

How many employees does ICU Medical have?

ICU Medical employs 8,500 workers across the globe.

When was ICU Medical founded?

ICU Medical was founded in 1984.

What is ICU Medical's official website?

The official website for ICU Medical is www.icumed.com.

How can I contact ICU Medical?

ICU Medical's mailing address is 951 CALLE AMANECER, SAN CLEMENTE CA, 92763. The medical instruments supplier can be reached via phone at (949) 366-2183, via email at [email protected], or via fax at 949-366-8368.

This page was last updated on 5/27/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.